Reply by Authors
J Urol
.
2020 Aug;204(2):246.
doi: 10.1097/JU.0000000000000798.03.
Epub 2020 May 27.
Authors
Joep J de Jong
1
,
Yang Liu
2
,
Stephen A Boorjian
3
,
Trinity J Bivalacqua
4
,
Sima P Porten
5
,
Thomas Wheeler
6
,
Elai Davicioni
2
,
Robert S Svatek
7
,
Joost L Boormans
1
,
Peter C Black
8
,
Yair Lotan
9
,
Ewan A Gibb
2
Affiliations
1
Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
2
Decipher Biosciences Inc., Vancouver, British Columbia.
3
Mayo Clinic, Rochester, Minnesota.
4
Johns Hopkins Medical Institutions, Baltimore, Maryland.
5
University of California San Francisco, San Francisco, California.
6
Baylor College of Medicine, Houston, Texas.
7
University of Texas Health San Antonio, San Antonio, Texas.
8
Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia.
9
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
PMID:
32459975
DOI:
10.1097/JU.0000000000000798.03
No abstract available
Publication types
Comment